MedWatch

Fluxome-CEO: We want to be among the best in the world

Ambitions are sky-high in the Danish biotech company Fluxome, and the first European distribution deals are almost in place.

Foto: Arkivfoto: Paul Bodea, Stock.xchng

The biotech company Fluxome Sciences A/S, which is now launching a food supplement – the substance of which is known as the health-giving property of red wine – in Europe, expects to become one of the world’s strongest actors on a rapidly expanding market, says temporarily instated CEO Jarne Elleholm, who is also a partner in Vækstfonden.

Fluxome’s clients for the product Fluxome Resveratrol are initially companies in the food supplements business.

Allerede abonnent? Log ind.

Læs hele artiklen

Få adgang i 14 dage for 0 kr.
Det kræver intet kreditkort, og du vil ikke overgå til et betalt abonnement efterfølgende.

  • Adgang til alle låste artikler
  • Modtag vores daglige nyhedsbreve
  • Fuld adgang til vores app
Der skete en fejl. Prøv venligst igen senere

Få fuld adgang til dig og dine kollegaer.

Start et gratis virksomhedsprøveabonnement

Mere fra MedWatch

Relaterede

Seneste nyt

MedWatch job

Se flere jobs

Se flere jobs

Watch job

Se flere jobs

Se flere jobs

Latest news

Seneste nyt fra Watch Medier